Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AGILENT TECHNOLOGIES, INC.A · Entity 3062 | Sr. Vice President | November 14, 2023 | November 30, 2023 |
| MYRIAD GENETICS INCMYGN · Entity 5953 | Director · President and CEO | June 11, 2026 | June 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AGILENT TECHNOLOGIES, INC.
Report date November 14, 2023 · Filed November 30, 2023 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 90,629.6096 |
Reported balance
After 2023-11-14 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2023-11-14 · Grant · Acquired 11,225 · Balance 90,629.6096 F1: On November 14, 2023, 11,225 shares of common stock of Agilent Technologies, Inc. were issued to the reporting person pursuant to the Agilent Technologies, Inc. Long-Term Performance Program. The shares are subject to a 1-year post-vest holding period. 1,682 shares were deferred pursuant to the Agilent Technologies, Inc. Deferred Compensation Plan. F2: 128.919 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock. F3: 178.8988 shares were acquired in an Employee Stock purchase plan under Section 423 of the Internal Revenue Code of 1986, as amended, in a transaction exempt under Rule 16b-3. F4: Includes 0.557 shares acquired through revenue credit allocations relating to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan. The reporting person has elected to defer these shares of common stock. |
| Common StockSEC Table I · non-derivative | Direct | 87,195.6096 |
Reported balance
After 2023-11-14 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2023-11-14 · Tax withholding · Disposed 3,434 · Balance 87,195.6096 F5: The reporting person surrendered 3,434 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Amended from the previous reported amount of 3,171 shares. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 14, 2023, 11,225 shares of common stock of Agilent Technologies, Inc. were issued to the reporting person pursuant to the Agilent Technologies, Inc. Long-Term Performance Program. The shares are subject to a 1-year post-vest holding period. 1,682 shares were deferred pursuant to the Agilent Technologies, Inc. Deferred Compensation Plan.
F2: 128.919 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock.
F3: 178.8988 shares were acquired in an Employee Stock purchase plan under Section 423 of the Internal Revenue Code of 1986, as amended, in a transaction exempt under Rule 16b-3.
F4: Includes 0.557 shares acquired through revenue credit allocations relating to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan. The reporting person has elected to defer these shares of common stock.
F5: The reporting person surrendered 3,434 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Amended from the previous reported amount of 3,171 shares.
MYRIAD GENETICS INC
Report date June 11, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,068,083 |
Reported balance
After 2026-06-11 transaction · row 1
1 source rowRow 1 · 2026-06-11 · Grant · Acquired 3,542 · Balance 1,068,083 F1: These shares were acquired under the Issuer's Amended and Restated 2012 Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were acquired under the Issuer's Amended and Restated 2012 Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2026 Filed Jun 12, 2026 22:06 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 3,542 | $3.94 | $13,941.31 |
DisclosureSEC source: 0001738340-26-000006 · wk-form4_1781301961.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,068,083 F1 · shares: These shares were acquired under the Issuer's Amended and Restated 2012 Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| March 14, 2026 Filed Mar 16, 2026 21:05 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 10,816 | $4.66 | $50,402.56 |
DisclosureSEC source: 0001738340-26-000004 · wk-form4_1773695121.xml · nonDerivative · entry 3 Raha Samraat S. · CIK 0001738340 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,064,541 F2 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026. Read SEC document |
| March 13, 2026 Filed Mar 16, 2026 21:05 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 36,304 | $4.66 | $169,176.64 |
DisclosureSEC source: 0001738340-26-000004 · wk-form4_1773695121.xml · nonDerivative · entry 2 Raha Samraat S. · CIK 0001738340 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,075,357 F2 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 21:05 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 618,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001738340-26-000004 · wk-form4_1773695121.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,111,661 F1 · shares: Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 09, 2026 Filed Mar 9, 2026 23:03 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | PurchaseCommon Stock | 40,000 | $5.00 | $199,844.00 |
DisclosureSEC source: 0001738340-26-000002 · wk-form4_1773097390.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 493,104 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.97 to $5.00, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 21:47 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 29,634 | $7.30 | $216,328.20 |
DisclosureSEC source: 0001738340-25-000009 · wk-form4_1765576030.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,104 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 11, 2025. Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:24 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 1,498 | $3.56 | $5,335.88 |
DisclosureSEC source: 0001738340-25-000006 · wk-form4_1748895880.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 482,738 F1 · shares: These shares were acquired under the Myriad Genetics, Inc. Amended and Restated 2012 Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| April 30, 2025 Filed May 1, 2025 20:24 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantPerformance-Based Restricted Stock Units · Derivative | 141,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001738340-25-000003 · wk-form4_1746131053.xml · derivative · entry 1 Raha Samraat S. · CIK 0001738340 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,050 Underlying: Common Stock · 141,050 shares Expires not disclosed F1 · derivative.exercise_price: The shares subject to the performance-based restricted stock units ("PSUs") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026. F1 · derivative.exercise_date: The shares subject to the performance-based restricted stock units ("PSUs") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026. F1 · derivative.expiration_date: The shares subject to the performance-based restricted stock units ("PSUs") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026. Read SEC document |
| March 14, 2025 Filed Mar 17, 2025 20:19 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 7,649 | $10.07 | $77,025.43 |
DisclosureSEC source: 0001628280-25-013141 · wk-form4_1742242750.xml · nonDerivative · entry 2 Raha Samraat S. · CIK 0001738340 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 481,240 F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 14, 2025. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:19 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 216,495 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-013141 · wk-form4_1742242750.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 488,889 F1 · shares: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| December 11, 2024 Filed Dec 12, 2024 21:19 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 29,578 | $14.51 | $429,176.78 |
DisclosureSEC source: 0001738340-24-000004 · wk-form4_1734038333.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,394 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 11, 2024. Read SEC document |
| November 30, 2024 Filed Dec 2, 2024 21:17 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 1,118 | $13.83 | $15,461.94 |
DisclosureSEC source: 0001738340-24-000002 · wk-form4_1733174224.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 301,972 F1 · shares: These shares were acquired under the Myriad Genetics, Inc. 2012 Amended and Restated Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 20:44 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 64,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-011680 · wk-form4_1710794681.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,854 F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| December 11, 2023 Filed Dec 11, 2023 23:41 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 236,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001738340-23-000006 · wk-form4_1702338065.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,360 F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| November 17, 2023 Filed Nov 20, 2023 23:07 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 1,578 | $113.15 | $178,550.70 |
DisclosureSEC source: 0001127602-23-028021 · form4.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,107.6096 F1 · shares: The reporting person surrendered 1,578 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 17:17 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 345 | $114.19 | $39,395.55 |
DisclosureSEC source: 0001127602-23-027951 · form4.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,685.6096 F1 · shares: The reporting person surrendered 345 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 18:34 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 428 | $113.60 | $48,620.80 |
DisclosureSEC source: 0001127602-23-027752 · form4.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,030.6096 F1 · shares: The reporting person surrendered 428 shares to Agilent Technologies, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 14, 2023 Filed Nov 17, 2023 15:48 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 3,171 | $111.61 | $353,915.31 |
DisclosureSEC source: 0001127602-23-027714 · form4.xml · nonDerivative · entry 2 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,458.6096 F5 · shares: The reporting person surrendered 3,171 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 14, 2023 Filed Nov 17, 2023 15:48 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 11,225 | $111.61 | $1,252,822.25 |
DisclosureSEC source: 0001127602-23-027714 · form4.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,629.6096 F1 · shares: On November 14, 2023, 11,225 shares of common stock of Agilent Technologies, Inc. were issued to the reporting person pursuant to the Agilent Technologies, Inc. Long-Term Performance Program. The shares are subject to a 1-year post-vest holding period. 1,682 shares were deferred pursuant to the Agilent Technologies, Inc. Deferred Compensation Plan. F2 · balance_after: 128.919 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock. F3 · balance_after: 178.8988 shares were acquired in an Employee Stock purchase plan under Section 423 of the Internal Revenue Code of 1986, as amended, in a transaction exempt under Rule 16b-3. F4 · balance_after: Includes 0.557 shares acquired through revenue credit allocations relating to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan. The reporting person has elected to defer these shares of common stock. Read SEC document |
| November 14, 2023 Filed Nov 30, 2023 14:42 UTC Amendment | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 3,434 | $111.61 | $383,268.74 |
DisclosureSEC source: 0001127602-23-028439 · form4a.xml · nonDerivative · entry 2 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,195.6096 F5 · shares: The reporting person surrendered 3,434 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Amended from the previous reported amount of 3,171 shares. Read SEC document |
| November 14, 2023 Filed Nov 30, 2023 14:42 UTC Amendment | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 11,225 | $111.61 | $1,252,822.25 |
DisclosureSEC source: 0001127602-23-028439 · form4a.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,629.6096 F1 · shares: On November 14, 2023, 11,225 shares of common stock of Agilent Technologies, Inc. were issued to the reporting person pursuant to the Agilent Technologies, Inc. Long-Term Performance Program. The shares are subject to a 1-year post-vest holding period. 1,682 shares were deferred pursuant to the Agilent Technologies, Inc. Deferred Compensation Plan. F2 · balance_after: 128.919 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock. F3 · balance_after: 178.8988 shares were acquired in an Employee Stock purchase plan under Section 423 of the Internal Revenue Code of 1986, as amended, in a transaction exempt under Rule 16b-3. F4 · balance_after: Includes 0.557 shares acquired through revenue credit allocations relating to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan. The reporting person has elected to defer these shares of common stock. Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 18:59 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 1,120 | $146.19 | $163,732.80 |
DisclosureSEC source: 0001127602-22-026144 · form4.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,096.2348 F1 · shares: The reporting person surrendered 1,120 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 15:57 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 457 | $144.44 | $66,009.08 |
DisclosureSEC source: 0001127602-22-026123 · form4.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,216.2348 F1 · shares: The reporting person surrendered 457 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 19:57 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 344 | $147.12 | $50,609.28 |
DisclosureSEC source: 0001127602-22-026024 · form4.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,673.2348 F1 · shares: The reporting person surrendered 344 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 14:48 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantEmployee Stock Option (Right to Buy) · Derivative | 10,093 | $148.00 Strike: $148.00 | $1,493,764.00 |
DisclosureSEC source: 0001127602-22-025887 · form4.xml · derivative · entry 4 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,093 Underlying: Common Stock · 10,093 shares Expires 2032-11-15 F4 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. F5 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 14:48 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 7,646 | $148.00 | $1,131,608.00 |
DisclosureSEC source: 0001127602-22-025887 · form4.xml · nonDerivative · entry 3 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,017.2348 F3 · shares: The reporting person surrendered 7,646 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 14:48 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 20,566 | $148.00 | $3,043,768.00 |
DisclosureSEC source: 0001127602-22-025887 · form4.xml · nonDerivative · entry 2 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,663.2348 F2 · shares: On November 15, 2022, 20,566 shares of common stock of Agilent Technologies, Inc. were issued to the reporting person pursuant to the Agilent Technologies, Inc. Long-Term Performance Program. The shares are subject to a 1 year post-vest holding period. 4,133 shares were deferred pursuant to the Agilent Technologies, Inc. Deferred Compensation Plan. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 14:48 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 3,453 | $148.00 | $511,044.00 |
DisclosureSEC source: 0001127602-22-025887 · form4.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,097.2348 F1 · shares: Restricted Stock Units granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. The restricted stock units vest in four equal annual installments beginning on November 15, 2022 and are subject to a 1 year post-vest holding period. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 22:45 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 737 | $148.31 | $109,304.47 |
DisclosureSEC source: 0001127602-22-025645 · form4.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,644.2348 F1 · shares: The reporting person surrendered 737 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. F2 · balance_after: 44.005 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock. F3 · balance_after: 83.8119 shares were acquired in an Employee Stock Purchase Plan under Section 423 of the Internal Revenue Code of 1986, as amended, in a transaction exempt under Rule 16b-3. F4 · balance_after: Includes 2.085 shares acquired through revenue credit allocations relating to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan. The reporting person has elected to defer these shares of common stock. Read SEC document |
| May 13, 2022 Filed May 17, 2022 20:09 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 226 | $119.38 | $26,979.88 |
DisclosureSEC source: 0001127602-22-014730 · form4.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,251.3329 F1 · shares: The reporting person surrendered 226 shares to Agilent Technologies, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units in accordance with Rule 16b-3. F2 · balance_after: 45.0250 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock. F3 · balance_after: 102.5274 shares were acquired in an Employee Stock purchase plan under Section 423 of the Internal Revenue Code of 1986, as amended, in a transaction exempt under Rule 16b-3. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 18:15 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 1,121 | $164.30 | $184,180.30 |
DisclosureSEC source: 0000899243-21-045726 · doc4.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,544.7805 F1 · shares: The reporting person surrendered 1,121 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 19:21 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 457 | $161.54 | $73,823.78 |
DisclosureSEC source: 0001127602-21-029672 · form4.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,665.7805 F1 · shares: The reporting person surrendered 457 shares to Agilent Technologies, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 16, 2021 Filed Nov 19, 2021 02:26 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantEmployee Stock Option (Right to Buy) · Derivative | 10,669 | $161.39 Strike: $161.39 | $1,721,869.91 |
DisclosureSEC source: 0001127602-21-029625 · form4.xml · derivative · entry 4 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,669 Underlying: Common Stock · 10,669 shares Expires 2031-11-16 F4 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. F5 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated. Read SEC document |
| November 16, 2021 Filed Nov 19, 2021 02:26 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 8,696 | $161.39 | $1,403,447.44 |
DisclosureSEC source: 0001127602-21-029625 · form4.xml · nonDerivative · entry 3 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,122.7805 F3 · shares: The reporting person surrendered 8,696 shares to Agilent Technologies, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 16, 2021 Filed Nov 19, 2021 02:26 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 17,869 | $161.39 | $2,883,877.91 |
DisclosureSEC source: 0001127602-21-029625 · form4.xml · nonDerivative · entry 2 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,818.7805 F2 · shares: On November 16, 2021, 17,869 shares of common stock of Agilent Technologies, Inc. were issued to the reporting person pursuant to the Agilent Technologies, Inc. Long-Term Performance Program. The shares are subject to a 1 year post-vest holding period. Read SEC document |
| November 16, 2021 Filed Nov 19, 2021 02:26 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 2,774 | $161.39 | $447,695.86 |
DisclosureSEC source: 0001127602-21-029625 · form4.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,949.7805 F1 · shares: Restricted Stock Units granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. The restricted stock units vest in four equal annual installments beginning on November 16, 2022 and are subject to a 1 year post-vest holding period. Read SEC document |
| November 16, 2021 Filed Dec 17, 2021 15:25 UTC Amendment | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantEmployee Stock Option (Right to Buy) · Derivative | 10,669 | $161.39 Strike: $161.39 | $1,721,869.91 |
DisclosureSEC source: 0001127602-21-031207 · form4a.xml · derivative · entry 4 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,669 Underlying: Common Stock · 10,669 shares Expires 2031-11-16 F4 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. F5 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated. Read SEC document |
| November 16, 2021 Filed Dec 17, 2021 15:25 UTC Amendment | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 6,648 | $161.39 | $1,072,920.72 |
DisclosureSEC source: 0001127602-21-031207 · form4a.xml · nonDerivative · entry 3 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,170.7805 F3 · shares: The reporting person surrendered 6,648 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Amended from the previously reported amount of 8,696 shares. Read SEC document |
| November 16, 2021 Filed Dec 17, 2021 15:25 UTC Amendment | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 17,869 | $161.39 | $2,883,877.91 |
DisclosureSEC source: 0001127602-21-031207 · form4a.xml · nonDerivative · entry 2 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,818.7805 F2 · shares: On November 16, 2021, 17,869 shares of common stock of Agilent Technologies, Inc. were issued to the reporting person pursuant to the Agilent Technologies, Inc. Long-Term Performance Program. The shares are subject to a 1 year post-vest holding period. Amended to report 5,895 shares were deferred pursuant to the Agilent Technologies, Inc. Deferred Compensation Plan. Read SEC document |
| November 16, 2021 Filed Dec 17, 2021 15:25 UTC Amendment | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 2,774 | $161.39 | $447,695.86 |
DisclosureSEC source: 0001127602-21-031207 · form4a.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,949.7805 F1 · shares: Restricted Stock Units granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. The restricted stock units vest in four equal annual installments beginning on November 16, 2022 and are subject to a 1 year post-vest holding period. Read SEC document |
| November 16, 2021 Filed Feb 3, 2022 00:30 UTC Amendment | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantEmployee Stock Option (Right to Buy) · Derivative | 10,669 | $161.39 Strike: $161.39 | $1,721,869.91 |
DisclosureSEC source: 0001127602-22-003070 · form4a.xml · derivative · entry 4 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,669 Underlying: Common Stock · 10,669 shares Expires 2031-11-16 F4 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. F5 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated. Read SEC document |
| November 16, 2021 Filed Feb 3, 2022 00:30 UTC Amendment | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 5,911 | $161.39 | $953,976.29 |
DisclosureSEC source: 0001127602-22-003070 · form4a.xml · nonDerivative · entry 3 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,907.7805 F3 · shares: The reporting person surrendered 5,911 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Amended from the previously reported amount of 6,648 shares. Read SEC document |
| November 16, 2021 Filed Feb 3, 2022 00:30 UTC Amendment | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 17,869 | $161.39 | $2,883,877.91 |
DisclosureSEC source: 0001127602-22-003070 · form4a.xml · nonDerivative · entry 2 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,818.7805 F2 · shares: On November 16, 2021, 17,869 shares of common stock of Agilent Technologies, Inc. were issued to the reporting person pursuant to the Agilent Technologies, Inc. Long-Term Performance Program. The shares are subject to a 1 year post-vest holding period. Read SEC document |
| November 16, 2021 Filed Feb 3, 2022 00:30 UTC Amendment | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 2,774 | $161.39 | $447,695.86 |
DisclosureSEC source: 0001127602-22-003070 · form4a.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,949.7805 F1 · shares: Restricted Stock Units granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. The restricted stock units vest in four equal annual installments beginning on November 16, 2022 and are subject to a 1 year post-vest holding period. Read SEC document |
| November 12, 2021 Filed Nov 17, 2021 02:08 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 737 | $160.88 | $118,568.56 |
DisclosureSEC source: 0001127602-21-029388 · form4.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,175.7805 F1 · shares: The reporting person surrendered 737 shares to Agilent Technologies, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units in accordance with Rule 16b-3. F2 · balance_after: Includes 0.96 shares acquired through revenue credit allocations relating to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan. F3 · balance_after: 19.53 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan. F4 · balance_after: 105.52 shares were acquired in an Employee Stock purchase plan under Section 423 of the Internal Revenue Code of 1986, as amended, in a transaction exempt under Rule 16b-3. Read SEC document |
| May 14, 2021 Filed May 18, 2021 19:59 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 1,268 | $131.15 | $166,298.20 |
DisclosureSEC source: 0001127602-21-017164 · form4.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,786.7812 F1 · shares: The reporting person surrendered 1,268 shares to Agilent Technologies, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units in accordance with Rule 16b-3. F2 · balance_after: 11.027 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan. F3 · balance_after: 107.7197 shares were acquired in an Employee Stock purchase plan under Section 423 of the Internal Revenue Code of 1986, as amended, in a transaction exempt under Rule 16b-3. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 21:48 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | SaleCommon Stock | 1,000 | $127.50 | $127,500.00 |
DisclosureSEC source: 0000899243-21-014367 · doc4.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,936.0345 F1 · balance_after: 12.497 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 17:35 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 8,343 | $108.68 | $906,717.24 |
DisclosureSEC source: 0001127602-20-029809 · form4.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,922.5375 F1 · shares: The reporting person surrendered 8,343 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 19, 2020 Filed Jan 21, 2021 18:51 UTC Amendment | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Tax withholdingCommon Stock | 11,342 | $108.68 | $1,232,648.56 |
DisclosureSEC source: 0001127602-21-002248 · form4a.xml · nonDerivative · entry 1 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,923.5375 F1 · shares: The reporting person surrendered 11,342 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3. Amended from the previously reported amount of 8,343 shares. Read SEC document |
| November 17, 2020 Filed Nov 20, 2020 01:14 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantEmployee Stock Option (Right-to-Buy) · Derivative | 15,404 | $0.00 Strike: $109.86 | $0.00 |
DisclosureSEC source: 0001127602-20-029642 · form4.xml · derivative · entry 4 Raha Samraat S. · CIK 0001738340 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,404 Underlying: Common Stock · 15,404 shares Expires 2030-11-17 F4 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. F5 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.